文献速递消化道肿瘤放疗放疗物理与技术

术中放疗在可切除胰腺癌中的作用:系统综述与荟萃分析

The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis.
PubMed 文献 · Radiat Oncol · 2020-04-09

该系统综述与荟萃分析检索MEDLINE/PubMed、EMBASE和Cochrane Library截至2019年2月28日的文献,纳入15项研究共834例可切除胰腺癌患者,比较手术联合或不联合术中放疗的临床结局。汇总分析显示术中放疗组总生存更优(MSR 1.20,95%CI 1.06-1.37,P=0.005),局部复发率显著降低(RR 0.70,95%CI 0.51-0.97,P=0.03),术后并发症与手术相关死亡率两组相似。

要点

  • 可切除胰腺癌术中放疗组总生存优于未放疗组(MSR 1.20,95%CI 1.06-1.37,P=0.005)。
  • 术中放疗组局部复发率显著降低(RR 0.70,95%CI 0.51-0.97,P=0.03)。
  • 术后并发症与手术相关死亡率两组相似,未因术中放疗增加。

核心结论

  • 术中放疗显著改善可切除胰腺癌患者的局部控制和总生存,且未增加术后并发症和手术相关死亡率。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE/PubMed、EMBASE和Cochrane Library截至2019年2月28日发表的文献。
  • 共筛选1095项研究,最终纳入15项研究、834例患者,其中401例接受胰腺切除联合术中放疗,433例仅接受手术未行术中放疗。
  • 采用随机效应模型进行荟萃分析,主要结局包括中位生存时间、局部复发、术后并发症和手术相关死亡率。

主要发现

  • 术中放疗组总生存优于未放疗组(中位生存率MSR 1.20,95%CI 1.06-1.37,P=0.005)。
  • 术中放疗组局部复发率显著低于未放疗组(RR 0.70,95%CI 0.51-0.97,P=0.03)。
  • 术后并发症发生率两组相似(RR 0.95,95%CI 0.73-1.23)。
  • 手术相关死亡率两组相似(RR 1.07,95%CI 0.44-2.63)。

关键数值与推荐

  • 可切除胰腺癌患者接受胰腺切除联合术中放疗对比单纯手术:总生存MSR 1.20(95%CI 1.06-1.37,P=0.005),局部复发RR 0.70(95%CI 0.51-0.97,P=0.03)。
  • 术后并发症RR 0.95(95%CI 0.73-1.23),手术相关死亡率RR 1.07(95%CI 0.44-2.63),两组间无显著差异。

临床怎么用

  • 对于可切除胰腺癌,在手术切除基础上联合术中放疗可作为改善局部控制和总生存的选项,且不增加术后并发症与手术相关死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Several studies investigating the role of intraoperative radiotherapy (IORT) in the treatment of resectable pancreatic cancer (PC) have been published; however, their results remain inconsistent. By conducting a systematic review and meta-analysis, this study aimed to compare clinical outcomes in patients with resectable PC who underwent surgery with or without IORT. METHODS AND MATERIALS: The MEDLINE/PubMed, EMBASE, and Cochrane Library databases were searched to identify relevant studies published up to February 28, 2019. The main outcome measures included median survival time (MST), local recurrence (LR), postoperative complications, and operation-related mortality. Pooled effect estimates were obtained by performing a random-effects meta-analysis. RESULTS: A total of 1095 studies were screened for inclusion, of which 15 studies with 834 patients were included in the meta-analysis. Overall, 401 patients underwent pancreatic resection with IORT and 433 underwent surgery without IORT. The pooled analysis revealed that IORT group experienced favorable overall survival (median survival rate [MSR], 1.20; 95% confidence interval [CI], 1.06-1.37, P = 0.005), compared with patients who did not receive IORT. Additionally, the pooled data showed a significantly reduced LR rate in the IORT group compared with that in the non-IORT group (relative risk [RR], 0.70; 95% CI, 0.51-0.97, P = 0.03). The incidences of postoperative complications (RR, 0.95; 95% CI, 0.73-1.23) and operation-related mortality (RR, 1.07; 95% CI, 0.44-2.63) were similar between the IORT and non-IORT groups. CONCLUSION: IORT significantly improved locoregional control and overall survival in patients with resectable PC, without increasing postoperative complications and operation-related mortality rates.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Jin L, Shi N, Ruan S, et al. The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis. Radiat Oncol. 2020. PMID: 32272945. doi:10.1186/s13014-020-01511-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。